These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9184709)
1. The use of alternate-day lovastatin in hypercholesterolemic men. Dennis VC; Britton ML; Sirmans SM; Letassy NA; Freeman DA Ann Pharmacother; 1997 Jun; 31(6):708-12. PubMed ID: 9184709 [TBL] [Abstract][Full Text] [Related]
2. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910 [TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
4. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. Arca M; Vega GL; Grundy SM JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia. Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia. Strauss WE; Lapsley D; Gaziano JM Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626 [TBL] [Abstract][Full Text] [Related]
8. Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity. Heudebert GR; Van Ruiswyk J; Hiatt J; Schectman G Arch Intern Med; 1993 Aug; 153(15):1828-37. PubMed ID: 8333817 [TBL] [Abstract][Full Text] [Related]
9. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Agrawal AR; Tandon M; Sharma PL Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545 [TBL] [Abstract][Full Text] [Related]
10. A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin. Davidson MH; Lukacsko P; Sun JX; Phillips G; Walters E; Sterman A; Niecestro R; Friedhoff L Clin Ther; 2002 Jan; 24(1):112-25. PubMed ID: 11833826 [TBL] [Abstract][Full Text] [Related]
11. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia]. Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396 [TBL] [Abstract][Full Text] [Related]
12. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. Clearfield M; Downs JR; Weis S; Whitney EJ; Kruyer W; Shapiro DR; Stein EA; Langendorfer A; Beere PA; Gotto AM J Womens Health Gend Based Med; 2001 Dec; 10(10):971-81. PubMed ID: 11788107 [TBL] [Abstract][Full Text] [Related]
13. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864 [TBL] [Abstract][Full Text] [Related]
14. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232 [TBL] [Abstract][Full Text] [Related]
15. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM; Barnett MD; Wright JT; Proctor JP Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1993 Jan; 71(1):82-7. PubMed ID: 8093585 [TBL] [Abstract][Full Text] [Related]
17. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study]. Forti N; Ramires JA Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203 [TBL] [Abstract][Full Text] [Related]
18. Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Davidson MH; Toth P; Weiss S; McKenney J; Hunninghake D; Isaacsohn J; Donovan JM; Burke SK Clin Cardiol; 2001 Jun; 24(6):467-74. PubMed ID: 11403509 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia. Yu WC; Chen CH; Tsao HM; Ding YA Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566 [TBL] [Abstract][Full Text] [Related]